Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
Completed
Solvay Pharmaceuticals
Phase 4
2005-11-01
This study is to evaluate the effects of continuously combined 17b-estradiol/dydrogesterone
in comparison with tibolone on the breast metabolic markers, in particular the total
insulin-like growth factor-1 (IGF-1), in postmenopausal women.
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
Completed
Abbott Products
Phase 3
2003-09-01
The purpose of this clinical study is to demonstrate the shift from inflammatory cytokines to
non-inflammatory cytokines in women suffering from habitual abortion treated with
dydrogesterone (Duphaston).
Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
Completed
Solvay Pharmaceuticals
Phase 3
2005-12-01
To demonstrate efficacy of continuous combined 0.5 mg estradiol and 2.5 mg dydrogesterone
versus placebo in the treatment of vasomotor symptoms after a treatment period of 3 months
and to investigate the bleeding pattern over a treatment period of one year
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
